Celltrion Pharm, Inc. (KOSDAQ:068760)
62,000
-100 (-0.16%)
At close: Dec 5, 2025
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.70 trillion as of December 5, 2025. Its market cap has increased by 6.20% in one year.
Market Cap
2.70T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
104.20
Stock Price
62,000.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.70T, an increase of 3,963.29%. That is a compound annual growth rate of 20.52%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8,755.13B |
| LigaChem Biosciences | 7,139.05B |
| Peptron | 6,540.52B |